Literature DB >> 23796454

Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.

Julie E Pickett1, Kunihiko Nagakura, Anna R Pasternak, Steven G Grinnell, Susruta Majumdar, Jason S Lewis, Gavril W Pasternak.   

Abstract

Standard radioiodination methods lack site-selectivity and either mask charges (Bolton-Hunter) or involve oxidative reaction conditions (chloramine-T). Opioid peptides are very sensitive to certain structural modifications, making these labeling methods untenable. In our model opioid peptide, α-neoendorphin, we replaced a tyrosyl hydroxyl with an iodine, and in cell lines stably expressing mu, delta, or kappa opioid receptors, we saw no negative effects on binding. We then optimized a repurposed Sandmeyer reaction using copper(I) catalysts with non-redoxing/non-nucleophilic ligands, bringing the radiochemical yield up to around 30%, and site-selectively incorporated radioactive iodine into this position under non-oxidizing reaction conditions, which should be broadly compatible with most peptides. The (125)I- and (131)I-labeled versions of the compound bound with high affinity to opioid receptors in mouse brain homogenates, thus demonstrating the general utility of the labeling strategy and of the peptide for exploring opioid binding sites.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23796454      PMCID: PMC3725135          DOI: 10.1016/j.bmcl.2013.05.090

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  25 in total

1.  Therapeutic radiopharmaceuticals.

Authors:  W A Volkert; T J Hoffman
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.

Authors:  Q Jiang; A E Takemori; M Sultana; P S Portoghese; W D Bowen; H I Mosberg; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

3.  Molecular insights into mu opioid pharmacology: From the clinic to the bench.

Authors:  Gavril W Pasternak
Journal:  Clin J Pain       Date:  2010-01       Impact factor: 3.442

4.  Generation of novel radiolabeled opiates through site-selective iodination.

Authors:  Susruta Majumdar; Maxim Burgman; Nathan Haselton; Steven Grinnell; Julia Ocampo; Anna Rose Pasternak; Gavril W Pasternak
Journal:  Bioorg Med Chem Lett       Date:  2011-05-08       Impact factor: 2.823

5.  Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.

Authors:  R B Rothman; V Bykov; B R de Costa; A E Jacobson; K C Rice; L S Brady
Journal:  Peptides       Date:  1990 Mar-Apr       Impact factor: 3.750

6.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

7.  delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.

Authors:  M Sofuoglu; P S Portoghese; A E Takemori
Journal:  Eur J Pharmacol       Date:  1992-06-05       Impact factor: 4.432

8.  Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively.

Authors:  A E Takemori; P S Portoghese
Journal:  Eur J Pharmacol       Date:  1993-09-28       Impact factor: 4.432

Review 9.  Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling.

Authors:  D S Wilbur
Journal:  Bioconjug Chem       Date:  1992 Nov-Dec       Impact factor: 4.774

10.  Classification of multiple morphine and enkephalin binding sites in the central nervous system.

Authors:  B L Wolozin; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  1 in total

1.  Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analogues.

Authors:  Robyn Pescatore; Gina F Marrone; Seth Sedberry; Daniel Vinton; Netanel Finkelstein; Yitzchak E Katlowitz; Gavril W Pasternak; Krista R Wilson; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-04-14       Impact factor: 4.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.